AP2514A - HIV reverse transcriptase inhibitors - Google Patents
HIV reverse transcriptase inhibitorsInfo
- Publication number
- AP2514A AP2514A AP2009004759A AP2009004759A AP2514A AP 2514 A AP2514 A AP 2514A AP 2009004759 A AP2009004759 A AP 2009004759A AP 2009004759 A AP2009004759 A AP 2009004759A AP 2514 A AP2514 A AP 2514A
- Authority
- AP
- ARIPO
- Prior art keywords
- reverse transcriptase
- transcriptase inhibitors
- hiv reverse
- hiv
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83280606P | 2006-07-24 | 2006-07-24 | |
| PCT/US2007/016703 WO2008016522A2 (en) | 2006-07-24 | 2007-07-24 | Hiv reverse transcriptase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AP2009004759A0 AP2009004759A0 (en) | 2009-02-28 |
| AP2514A true AP2514A (en) | 2012-11-23 |
Family
ID=38997642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AP2009004759A AP2514A (en) | 2006-07-24 | 2007-07-24 | HIV reverse transcriptase inhibitors |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20100034827A1 (ja) |
| EP (1) | EP2044037A2 (ja) |
| JP (1) | JP2009544710A (ja) |
| KR (2) | KR20110089463A (ja) |
| CN (1) | CN101495461A (ja) |
| AP (1) | AP2514A (ja) |
| AU (1) | AU2007281604A1 (ja) |
| BR (1) | BRPI0714880A2 (ja) |
| CA (1) | CA2658479A1 (ja) |
| EA (1) | EA200900213A1 (ja) |
| HR (1) | HRP20090114A2 (ja) |
| IL (1) | IL196675A0 (ja) |
| MX (1) | MX2009000871A (ja) |
| NO (1) | NO20090835L (ja) |
| NZ (1) | NZ573793A (ja) |
| SG (1) | SG174016A1 (ja) |
| UA (1) | UA95955C2 (ja) |
| WO (1) | WO2008016522A2 (ja) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101495461A (zh) | 2006-07-24 | 2009-07-29 | 吉里德科学公司 | 新的hiv逆转录酶抑制剂 |
| US8354421B2 (en) * | 2007-06-29 | 2013-01-15 | Korea Research Insitute Of Chemical Technology | HIV reverse transcriptase inhibitors |
| TW200918507A (en) * | 2007-06-29 | 2009-05-01 | Gilead Sciences Inc | Novel HIV reverse transcriptase inhibitors |
| WO2009085797A1 (en) | 2007-12-21 | 2009-07-09 | Gilead Sciences, Inc. | Processes for preparing hiv reverse transcriptase inhibitors |
| MX2010013275A (es) * | 2008-06-03 | 2011-03-15 | Taiho Pharmaceutical Co Ltd | Compuesto novedoso de uracilo o su sal que tiene actividad inhibidora de desoxiuridin trifosfatasa de humano. |
| US8846096B2 (en) * | 2008-12-12 | 2014-09-30 | Creighton University | Nanoparticles and methods of use |
| US8921415B2 (en) | 2009-01-29 | 2014-12-30 | Mapi Pharma Ltd. | Polymorphs of darunavir |
| EP2399910B1 (en) | 2009-02-13 | 2014-04-02 | Shionogi&Co., Ltd. | Triazine derivatives as p2x3 and/or p2x2/3 receptor antagonists and pharmaceutical composition containing them |
| GB0908394D0 (en) | 2009-05-15 | 2009-06-24 | Univ Leuven Kath | Novel viral replication inhibitors |
| EP2342186B1 (en) * | 2009-06-22 | 2014-09-17 | Emcure Pharmaceuticals Limited | Process for synthesis of etravirine |
| GB0913636D0 (en) | 2009-08-05 | 2009-09-16 | Univ Leuven Kath | Novel viral replication inhibitors |
| WO2011092687A1 (en) | 2010-01-28 | 2011-08-04 | Mapi Pharma Hk Limited | Process for the preparation of darunavir and darunavir intermediates |
| US20110262406A1 (en) | 2010-04-21 | 2011-10-27 | Yale University | Compositions and methods for targeted inactivation of hiv cell surface receptors |
| US20110293585A1 (en) | 2010-04-21 | 2011-12-01 | Helix Therapeutics, Inc. | Compositions and methods for treatment of lysosomal storage disorders |
| KR101867110B1 (ko) | 2010-08-10 | 2018-06-12 | 시오노기 앤드 컴파니, 리미티드 | 트라이아진 유도체 및 그것을 함유하는 진통 작용을 갖는 의약 조성물 |
| WO2012020742A1 (ja) * | 2010-08-10 | 2012-02-16 | 塩野義製薬株式会社 | 新規複素環誘導体およびそれらを含有する医薬組成物 |
| MY158809A (en) * | 2010-09-22 | 2016-11-15 | Craun Res Sdn Bhd | Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same |
| JP2013542243A (ja) | 2010-11-15 | 2013-11-21 | カトリーケ ウニヴェルシテイト ルーヴェン | 新規な抗ウイルス性化合物 |
| TWI689513B (zh) | 2011-10-07 | 2020-04-01 | 美商基利科學股份有限公司 | 抗病毒核苷酸類似物的製備方法 |
| EP2785184B1 (en) | 2011-11-30 | 2020-06-10 | Emory University | Compositions comprising jak inhibitors and haart drugs for use in the prevention or treatment of hiv |
| RU2598627C2 (ru) | 2012-01-19 | 2016-09-27 | Дзе Джонс Хопкинс Юниверсити | Композиции на основе наночастиц с улучшенным проникновением через слизистые оболочки |
| WO2013118855A1 (ja) | 2012-02-09 | 2013-08-15 | 塩野義製薬株式会社 | 複素環および炭素環誘導体 |
| WO2014107622A1 (en) | 2013-01-07 | 2014-07-10 | University Of Southern California | Deoxyuridine triphosphatase inhibitors |
| WO2014124006A1 (en) | 2013-02-05 | 2014-08-14 | The Johns Hopkins University | Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof |
| TWI637949B (zh) | 2013-06-14 | 2018-10-11 | 塩野義製藥股份有限公司 | 胺基三衍生物及含有其等之醫藥組合物 |
| JP6513095B2 (ja) | 2014-01-03 | 2019-05-15 | ユニバーシティ オブ サザン カリフォルニア | ヘテロ原子含有デオキシウリジントリホスファターゼ阻害剤 |
| WO2015127389A1 (en) | 2014-02-23 | 2015-08-27 | The Johns Hopkins University | Hypotonic enema formulations and methods of use |
| SG11201705069YA (en) | 2014-12-26 | 2017-07-28 | Univ Emory | N4-hydroxycytidine and derivatives and anti-viral uses related thereto |
| AU2016211696B2 (en) | 2015-01-27 | 2018-05-10 | The Johns Hopkins University | Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces |
| US10570100B2 (en) | 2015-07-08 | 2020-02-25 | University Of Southern California | Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage |
| EP3319939A1 (en) | 2015-07-08 | 2018-05-16 | CV6 Therapeutics (NI) Limited | Hydantoin containing deoxyuridine triphosphatase inhibitors |
| WO2017006270A1 (en) | 2015-07-08 | 2017-01-12 | University Of Southern California | Deoxyuridine triphosphatase inhibitors |
| US10544105B2 (en) | 2015-07-08 | 2020-01-28 | Cv6 Therapeutics (Ni) Limited | Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage |
| US10858344B2 (en) | 2016-11-23 | 2020-12-08 | Cv6 Therapeutics (Ni) Limited | Hydantoin containing deoxyuridine triphosphatase inhibitors |
| WO2018098208A1 (en) | 2016-11-23 | 2018-05-31 | Cv6 Therapeutics (Ni) Limited | Nitrogen ring linked deoxyuridine triphosphatase inhibitors |
| WO2018098204A1 (en) | 2016-11-23 | 2018-05-31 | Cv6 Therapeutics (Ni) Limited | 6-membered uracil isosteres |
| WO2018098207A1 (en) | 2016-11-23 | 2018-05-31 | Cv6 Therapeutics (Ni) Limited | Hydantoin containing deoxyuridine triphosphatase inhibitors |
| WO2018098209A1 (en) | 2016-11-23 | 2018-05-31 | Cv6 Therapeutics (Ni) Limited | Amino sulfonyl compounds |
| US11247984B2 (en) | 2017-01-05 | 2022-02-15 | Cv6 Therapeutics (Ni) Limited | Uracil containing compounds |
| PE20191835A1 (es) * | 2017-03-17 | 2019-12-30 | Meiji Seika Pharma Co Ltd | Agente de control de enfermedades de plantas |
| EP3706762A4 (en) | 2017-12-07 | 2021-09-01 | Emory University | N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTIVIRAL USES IN RELATION TO IT |
| CN115536596A (zh) * | 2022-11-08 | 2022-12-30 | 巨鑫生物制药股份有限公司 | 一种acc007中间体的制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000051990A1 (en) * | 1999-03-04 | 2000-09-08 | Korea Research Institute Of Chemical Technology | Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof |
| WO2000061564A1 (en) * | 1999-04-10 | 2000-10-19 | Samjin Pharmaceutical Co., Ltd. | Antiviral pyrimidinedione derivatives and process for the preparation thereof |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4656209A (en) | 1982-05-26 | 1987-04-07 | Ciba-Geigy Corporation | Chlorinated thermoplastics stabilized with aminouracils |
| KR0155168B1 (ko) | 1989-09-29 | 1998-11-16 | 미우라 아끼라 | 6-치환된 아시클로피리미딘 뉴클레오시드 유도체 및 이를 활성성분으로 함유하는 항비루스제 |
| EP0442473B1 (en) | 1990-02-15 | 1998-08-19 | Takeda Chemical Industries, Ltd. | Pyrimidinedione derivatives, their production and use |
| IL99731A0 (en) * | 1990-10-18 | 1992-08-18 | Merck & Co Inc | Hydroxylated pyridine derivatives,their preparation and pharmaceutical compositions containing them |
| AU693107B2 (en) | 1994-02-28 | 1998-06-25 | Sunkyong Industries Co., Ltd. | Pyrimidine acyclonucleoside derivatives |
| JPH083143A (ja) | 1994-06-21 | 1996-01-09 | Mitsubishi Chem Corp | ６−アラルキル置換ピリミジン誘導体の製造方法 |
| US6174998B1 (en) | 1996-03-12 | 2001-01-16 | Roche Diagnostics Gmbh | C-nucleoside derivatives and their use in the detection of nucleic acids |
| JP3049095B2 (ja) | 1996-02-22 | 2000-06-05 | サムジン ファーマシューチカル カンパニー，リミテッド | 新規抗ウイルス性置換ピリミジンジオン単素炭素環式ヌクレオシド誘導体及びその製造方法とこれを活性成分として含有する組成物 |
| KR100219922B1 (ko) | 1996-05-16 | 1999-09-01 | 이서봉 | 신규한 항바이러스성 6-아릴옥시 및 6-아릴카르보닐 2,4-피리미딘디온 유도체 및 그의 제조 방법 |
| JPH10130244A (ja) | 1996-09-06 | 1998-05-19 | Mitsubishi Chem Corp | アシクロヌクレオシドの製造方法 |
| JPH10130245A (ja) | 1996-09-06 | 1998-05-19 | Mitsubishi Chem Corp | アシクロヌクレオシドの製造方法 |
| CA2268953A1 (en) | 1996-10-02 | 1998-04-09 | Du Pont Pharmaceuticals Company | 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same |
| JPH10168068A (ja) | 1996-12-05 | 1998-06-23 | Mitsubishi Chem Corp | アシクロヌクレオシドの製造方法 |
| US5998411A (en) | 1998-03-17 | 1999-12-07 | Hughes Institute | Heterocyclic nonnucleoside inhibitors of reverse transcriptase |
| WO1999050253A1 (en) * | 1998-03-27 | 1999-10-07 | Du Pont Pharmaceuticals Company | 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors |
| FR2779722A1 (fr) | 1998-06-15 | 1999-12-17 | Expansia Sa | Hydrogenation de 6-alpha-alkylcarboxy methylaryl-1,5-dialkyl uracile |
| FR2779721A1 (fr) | 1998-06-15 | 1999-12-17 | Expansia Sa | Substitution d'une 1,5-dialkyl uracile en position 6 |
| AU7450300A (en) | 1999-09-29 | 2001-04-30 | Sankyo Company Limited | Sulfonamide derivatives |
| JP2001114767A (ja) | 1999-10-15 | 2001-04-24 | Sumika Fine Chemicals Co Ltd | ピリミジン化合物の製造方法、およびその中間体の製造方法 |
| US6995283B2 (en) * | 2001-03-02 | 2006-02-07 | Smithkline Beecham Corporation | Benzophenones as inhibitors of reverse transcriptase |
| JP2002284686A (ja) | 2001-03-28 | 2002-10-03 | Sankyo Co Ltd | スルホンアミド化合物を含有する医薬組成物 |
| WO2003029226A1 (en) | 2001-09-26 | 2003-04-10 | Basf Aktiengesellschaft | Heterocyclyl substituted phenoxyalkyl-, phenylthioalkyl-, phenylaminoalkyl- and phenylalkyl-sulfamoylcarboxamides |
| WO2003057677A1 (en) | 2002-01-11 | 2003-07-17 | Syddansk Universitet | Anti-retroviral 5,6-disubstituted acyclopyrimidine nucleoside derivatives |
| DE60309665T2 (de) | 2002-01-31 | 2007-09-20 | Ciba Speciality Chemicals Holding Inc. | Stabilisierung von polyolefinen, die in permanentem kontakt mit chloriertem wasser stehen |
| MXPA05002070A (es) * | 2002-08-23 | 2005-07-05 | Ribapharm Inc | Inhibidores no nucleosidicos de la transcriptasa inversa. |
| WO2006070292A2 (en) | 2004-10-12 | 2006-07-06 | Queen's University At Kingston | Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents |
| US7250421B2 (en) | 2005-01-31 | 2007-07-31 | University Of Georgia Research Foundation, Inc. | Diketo acids with nucleobase scaffolds: anti-HIV replication inhibitors targeted at HIV integrase |
| US20060223834A1 (en) | 2005-04-04 | 2006-10-05 | Vasu Nair | Diketo acids on nucleobase scaffolds as inhibitors of Flaviviridae |
| CL2006003736A1 (es) * | 2005-12-29 | 2008-05-16 | Janssen Pharmaceutica Nv | Compuestos derivados de triazina o pirimidina sustituida, antagonistas del receptor de prokineticina 1, composicion farmaceutica; y uso en el tratamiento de trastornos gastrointestinales. |
| CA2635845A1 (en) * | 2005-12-29 | 2007-07-12 | Janssen Pharmaceutica N.V. | Prokineticin 2 receptor antagonists |
| WO2007106450A2 (en) | 2006-03-10 | 2007-09-20 | University Of Georgia Research Foundation, Inc. | Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase in combination therapy |
| CN101495461A (zh) * | 2006-07-24 | 2009-07-29 | 吉里德科学公司 | 新的hiv逆转录酶抑制剂 |
| TW200918507A (en) * | 2007-06-29 | 2009-05-01 | Gilead Sciences Inc | Novel HIV reverse transcriptase inhibitors |
-
2007
- 2007-07-24 CN CNA2007800280617A patent/CN101495461A/zh active Pending
- 2007-07-24 US US12/373,237 patent/US20100034827A1/en not_active Abandoned
- 2007-07-24 BR BRPI0714880-1A patent/BRPI0714880A2/pt not_active IP Right Cessation
- 2007-07-24 KR KR1020117017501A patent/KR20110089463A/ko not_active Application Discontinuation
- 2007-07-24 SG SG2011054681A patent/SG174016A1/en unknown
- 2007-07-24 UA UAA200814467A patent/UA95955C2/ru unknown
- 2007-07-24 NZ NZ573793A patent/NZ573793A/en not_active IP Right Cessation
- 2007-07-24 AU AU2007281604A patent/AU2007281604A1/en not_active Abandoned
- 2007-07-24 JP JP2009521814A patent/JP2009544710A/ja active Pending
- 2007-07-24 CA CA002658479A patent/CA2658479A1/en not_active Abandoned
- 2007-07-24 MX MX2009000871A patent/MX2009000871A/es not_active Application Discontinuation
- 2007-07-24 AP AP2009004759A patent/AP2514A/xx active
- 2007-07-24 EA EA200900213A patent/EA200900213A1/ru unknown
- 2007-07-24 US US11/880,854 patent/US8106064B2/en not_active Expired - Fee Related
- 2007-07-24 WO PCT/US2007/016703 patent/WO2008016522A2/en active Application Filing
- 2007-07-24 KR KR1020097003836A patent/KR20090040449A/ko not_active Application Discontinuation
- 2007-07-24 EP EP07836229A patent/EP2044037A2/en not_active Withdrawn
-
2009
- 2009-01-22 IL IL196675A patent/IL196675A0/en unknown
- 2009-02-23 NO NO20090835A patent/NO20090835L/no not_active Application Discontinuation
- 2009-02-24 HR HR20090114A patent/HRP20090114A2/hr not_active Application Discontinuation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000051990A1 (en) * | 1999-03-04 | 2000-09-08 | Korea Research Institute Of Chemical Technology | Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof |
| WO2000061564A1 (en) * | 1999-04-10 | 2000-10-19 | Samjin Pharmaceutical Co., Ltd. | Antiviral pyrimidinedione derivatives and process for the preparation thereof |
Non-Patent Citations (1)
| Title |
|---|
| JI, LEI ET AL.: CHEM. PHARM. BULL., vol. 54, no. 9, 2006, pages 1248-1253, XP002494625 * |
Also Published As
| Publication number | Publication date |
|---|---|
| NO20090835L (no) | 2009-04-23 |
| US20100034827A1 (en) | 2010-02-11 |
| US20080070920A1 (en) | 2008-03-20 |
| MX2009000871A (es) | 2009-05-08 |
| WO2008016522A2 (en) | 2008-02-07 |
| AU2007281604A1 (en) | 2008-02-07 |
| IL196675A0 (en) | 2009-11-18 |
| WO2008016522A3 (en) | 2008-12-11 |
| NZ573793A (en) | 2012-01-12 |
| UA95955C2 (ru) | 2011-09-26 |
| EA200900213A1 (ru) | 2009-06-30 |
| CA2658479A1 (en) | 2008-02-07 |
| JP2009544710A (ja) | 2009-12-17 |
| KR20090040449A (ko) | 2009-04-24 |
| BRPI0714880A2 (pt) | 2013-05-21 |
| SG174016A1 (en) | 2011-09-29 |
| AP2009004759A0 (en) | 2009-02-28 |
| US8106064B2 (en) | 2012-01-31 |
| HRP20090114A2 (hr) | 2010-03-31 |
| EP2044037A2 (en) | 2009-04-08 |
| KR20110089463A (ko) | 2011-08-08 |
| CN101495461A (zh) | 2009-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2514A (en) | HIV reverse transcriptase inhibitors | |
| IL188615A0 (en) | Hiv reverse transcriptase inhibitors | |
| ZA201000023B (en) | Novel hiv reverse transcriptase inhibitors | |
| ZA200903395B (en) | Non-nucleoside reverse transcriptase inhibitors | |
| EP2220091A4 (en) | REVERSE transcriptase inhibitors | |
| IL196655A0 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| EP2076492A4 (en) | NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | |
| EP2217069A4 (en) | INHIBITORS OF NON-NUCLEOSIDE INHIBITORS OF THE REVERSE TRANSCRIPTASE | |
| IL205386A0 (en) | Non - nucleoside reverse transcriptase inhibitors | |
| IL200748A0 (en) | Non-nucleoside reverse transcriptse inhibitors | |
| IL197777A0 (en) | Enantiomerically pure phosphoindoles as hiv inhibitors | |
| TWI372619B (en) | Non-nucleoside reverse transcriptase inhibitors | |
| IL180495A0 (en) | Benzyltriazolone compounds as nin-nucleoside reverse transcriptase inhibitors | |
| IL194434A0 (en) | Hcv/hiv inhibitors and their uses | |
| ZA201101975B (en) | Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors | |
| EP2099789A4 (en) | INHIBITORS OF HIV REPLICATION | |
| SI2094702T1 (sl) | Virusni inhibitorji | |
| HK1127351A1 (zh) | 抗病毒蛋白酶抑制劑 | |
| EP2139883A4 (en) | INHIBITORS OF HIV-1 PROTEASE | |
| EP1756091A4 (en) | NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS | |
| IL200886A0 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| ZA200900071B (en) | Non-nucleoside reverse transcriptase inhibitors | |
| EP2134336A4 (en) | HIV PROTEASE INHIBITORS DERIVED FROM BENZOFURAN | |
| EP1899340A4 (en) | NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS | |
| ZA200800185B (en) | Hiv reverse transcriptase inhibitors |